HLA-C and cancer: In this proof-of-concept study, we investigated the generalizability of various StrB approaches in predicting peptide-MHC interactions, a pivotal aspect of immune surveillance and a major bottleneck in the design of cancer vaccines54–56 and TCR therapies57,58.